Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma

Area of Science:

• Immunogenetics
• Rheumatology
• Autoimmune Diseases

Background:

• Scleroderma (SSc) is a complex autoimmune disease characterized by fibrosis and vascular abnormalities.
• The role of Human Leukocyte Antigen (HLA) genes, particularly HLA-DR, in SSc susceptibility and its subtypes is an area of ongoing research.
• Understanding these associations can provide insights into disease pathogenesis and potential biomarkers.

Purpose of the Study:

• To investigate the association between HLA-DR antigens and scleroderma (SSc).
• To explore the relationship between HLA-DR and specific SSc subsets (diffuse vs. limited).
• To determine the association of HLA-DR with key autoantibodies in SSc patients.

Main Methods:

• HLA-DR antigen typing was performed on 45 Japanese patients diagnosed with SSc.
• Analysis focused on 22 SSc patients, excluding those with mixed connective tissue disease (MCTD) or overlap syndrome (OL).
• Statistical analysis was used to compare HLA-DR frequencies between SSc patients, controls, and subgroups based on disease presentation and autoantibody status.

Main Results:

• A significant increase in HLA-DR2 was observed in SSc patients (59%) compared to controls (29%), particularly in diffuse SSc (69%).
• HLA-DR2 was more frequent in patients with antitopoisomerase I antibodies (83%).
• HLA-DR1 was associated with limited SSc and anticentromere antibodies (ACA), with ACA-positive patients lacking HLA-DR2.

Conclusions:

• Distinct HLA-DR markers are associated with different SSc subtypes.
• Specific HLA-DR associations suggest a role in directing autoantibody production in diffuse and limited SSc.
• These findings highlight the immunogenetic underpinnings of SSc heterogeneity.